Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study

Autor: Lucie de Jonge, Iris Lansdorp-Vogelaar, Nicolas Iragorri, Veerle M.H. Coupé, Elisabeth F.P. Peterse, Joachim Worthington, Jie-Bin Lew, Francine van Wifferen, Eleonora Feletto, Marjolein J E Greuter, Karen Canfell, J. H. E. Yong, Heather Smith

Publikováno v: The Lancet Gastroenterology and Hepatology, 6(4), 304-314. Elsevier Ltd
The Lancet Gastroenterology and Hepatology, 6(4), 304-314. Elsevier Ltd.
de Jonge, L, Worthington, J, van Wifferen, F, Iragorri, N, Peterse, E F P, Lew, J B, Greuter, M J E, Smith, H A, Feletto, E, Yong, J H E, Canfell, K, Coupé, V M H, Lansdorp-Vogelaar, I & COVID-19 and Cancer Global Modelling Consortium working group 2 2021, ' Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands : a comparative modelling study ', The Lancet Gastroenterology and Hepatology, vol. 6, no. 4, pp. 304-314 . https://doi.org/10.1016/S2468-1253(21)00003-0
The Lancet Gastroenterology & Hepatology

Summary Background Colorectal cancer screening programmes worldwide have been disrupted during the COVID-19 pandemic. We aimed to estimate the impact of hypothetical disruptions to organised faecal immunochemical test-based colorectal cancer screenin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5114f6d9426c54181758ba39130ee8f
https://pubmed.ncbi.nlm.nih.gov/34015353

Participatory simulation modeling to inform colorectal cancer screening in a complex remote northern health system: Canada’s Northwest Territories

Autor: J. H. E. Yong, Heather Smith, Craig Kuziemsky, Kami Kandola, Robin P. Boushey

Publikováno v: International Journal of Medical Informatics. 150:104455

Background & aims Colorectal cancer (CRC) mortality in the Northwest Territories (NWT), a northern region of Canada, could be reduced by implementing a CRC screening program. However, this may require additional colonoscopy resources. We used partici

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10ca54f164d1279fa48509b9fba9018f
https://doi.org/10.1016/j.ijmedinf.2021.104455

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma

Autor: S J, Hotte, G A, Bjarnason, D Y C, Heng, M A S, Jewett, A, Kapoor, C, Kollmannsberger, J, Maroun, L A, Mayhew, S, North, M N, Reaume, J D, Ruether, D, Soulieres, P M, Venner, E W, Winquist, L, Wood, J H E, Yong, F, Saad

Publikováno v: Current oncology (Toronto, Ont.). 18

Traditionally, overall survival (os) has been considered the "gold standard" for evaluating new systemic oncologic therapies, because death is easy to define, is easily compared across disease sites, and is not subject to investigator bias. However,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::66ff2bc6850d99debd38523297473eb1
https://pubmed.ncbi.nlm.nih.gov/21969807